OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES Stock

Certificat

DE000GK9VKX7

Market Closed - BOERSE MUENCHEN 02:27:12 2024-07-12 pm EDT
1.445 EUR -7.90% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES
Current month-10.08%
1 month+9.72%
Date Price Change
24-07-12 1.445 -7.90%
24-07-11 1.569 -6.72%
24-07-10 1.682 +1.39%
24-07-08 1.659 -0.06%
24-07-05 1.66 -0.90%

Real-time BOERSE MUENCHEN

Last update July 12, 2024 at 02:27 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GK9VKX
ISINDE000GK9VKX7
Date issued 2022-09-01
Strike 130.3 $
Maturity Unlimited
Parity 25 : 1
Emission price 2.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.85
Lowest since issue 1.005

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
90.81 USD
Average target price
110.8 USD
Spread / Average Target
+22.06%
Consensus